Grifols Snapshot
Our mission is to improve the health and well-being of patients around the world.
We accomplish this mission by producing proteins for patients who face sometimes life-threatening conditions and by providing hospitals, pharmacies and healthcare professionals with the tools they need to enhance quality of life.
We accomplish this mission by producing proteins for patients who face sometimes life-threatening conditions and by providing hospitals, pharmacies and healthcare professionals with the tools they need to enhance quality of life.
Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions.
As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care.
Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society.
With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the sector. Our activity has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.
As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care.
Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society.
With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the sector. Our activity has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth.
